SID 2026Abstract 1064
Metabolomic analyses reveal metabolotypes that distinguish psoriasis patients by cutaneous disease severity and biologic therapy response
Bergendorf A, Cohn E, Abbad-Jaime de Aragón C, McCormick T, Cooper K, Bahn A, Brubaker D, González-Cantero Á, Treichel A
SID Annual Meeting 2026Preclinical studiesChicago, 13–16 May 2026 · published in JID 21 Jul 2026
Topics: PsoriasisSkin biologyBiologics
Abstract
The abstract’s text is on the JID website.
DOI 10.1016/j.jid.2026.06.1095 · Not in PubMed: details from Crossref